(-)-borneol [464-45-9]
Référence NB-64-25116-100mg
Conditionnement : 100mg
Marque : Neo Biotech
(-)-borneol (Synonyms: L-Borneol)
Catalog No. T3741 Copy Product Info
Purity: 99.02%
(-)-borneol (L-Borneol) has a highly efficacious positive modulating action at GABA receptor with an EC50 of 237 μM.
Select Batch
Purity:99.02%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
(-)-borneol AI Summary
(-)-borneol exhibits a binding affinity against human UDP Glucuronosyltransferase 1A4 (UGT1A4), with a Km value of 1100000.0 nM, and shows varying bioactivities across different human recombinant UGT isoforms. It demonstrates low or no activity in UGT1A1, UGT2B15, and UGT2B7H, while displaying moderate to high activity in UGT2A1, UGT2B7Y, and UGT1A4. The compound also exhibits antifungal activity against Colletotrichum acutatum, Colletotrichum gloeosporioides, and Colletotrichum fragariae, as observed in direct bioautography assays using 4 uL in 2 mM acetone, with complete growth inhibition. Furthermore, (-)-borneol displays cytotoxicity against HEK293 cells with a CC50 greater than 3000000.0 nM and inhibits Marburg virus envelope glycoprotein-mediated cell entry with an IC50 of 203000.0 nM. However, it shows weaker inhibition of Vesicular stomatitis Indiana virus envelope glycoprotein G-mediated cell entry with an IC50 greater than 650000.0 nM, yielding a selectivity index greater than 14.0 for Marburg virus..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | (-)-borneol (L-Borneol) has a highly efficacious positive modulating action at GABA receptor with an EC50 of 237 μM. |
| Targets&IC50 | GABA:237 μM(EC50) |
| Synonyms | L-Borneol |
| Molecular Weight | 154.25 |
| Formula | C10H18O |
| Cas No. | 464-45-9 |
| Smiles | C[C@]12C(C)(C)[C@](C[C@H]1O)(CC2)13 |
| Relative Density. | 0.992g/cm3 |
| Storage | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Chloroform: Soluble DMSO: 250 mg/mL (1620.75 mM), Sonication is recommended. ![]() Ethanol: Soluble | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (12.97 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||



